|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Oropouche Virus RNA, Qualitative Real-Time Reverse Transcriptase (RT) PCR
Test Code14328
CPT Codes
87798
Preferred Specimen
1.5 mL serum or
1.5 mL CSF collected in a plastic sterile leak-proof container
1.5 mL CSF collected in a plastic sterile leak-proof container
Minimum Volume
0.5 mL
Transport Container
Plastic sterile leak-proof container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Samples using heparin as anticoagulant
Methodology
Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Setup Schedule
Set up: Daily; Report available: 2-3 days
Reference Range
Not Detected
Clinical Significance
This test is intended for the detection of Oropouche virus (OROV) RNA in serum or CSF from patients with exposure, signs or symptoms consistent with OROV infection. It can be used to help in the diagnosis of Oropouche fever infection during the acute phase of the disease, which is typically within 7 days post-symptom onset. Serological testing can be considered for confirmatory diagnosis during the convalescent phase of this disease (greater than 7 days). This molecular test cannot distinguish between closely related reassortant OROVs within the Orthobunyavirus genus including Madre de Dios Virus, Iquitos Virus and Perdoes Virus. The results of this test should be interpreted in the context of pertinent clinical findings and history.
Reference
1. Wesselmann K, et al. Lancet infectious Diseases. 2024;24 :e439-452
Reference
1. Wesselmann K, et al. Lancet infectious Diseases. 2024;24 :e439-452